Skip to main navigation Skip to search Skip to main content

Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations

  • Georgirene D. Vladutiu
  • , Elizabeth J. Quackenbush
  • , Bryan E. Hainline
  • , Simone Albers
  • , David S. Smail
  • , Michael J. Bennett
  • Women and Children's Hospital of Buffalo
  • SUNY Buffalo
  • Boston Children's Hospital
  • Indiana University-Purdue University Indianapolis
  • University of Texas at Dallas

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

We describe a lethal neonatal form of carnitine palmitoyltransferase II (CPT II) deficiency with compound heterozygosity for 2 truncation mutations (Q413fs and 109AGC → GCAGC). A new phenotype for a severe late infantile form of CPT II deficiency with hypoglycemia is associated with compound heterozygosity for the severe Q413fs mutation and a mild point mutation (P50H).

Original languageEnglish
Pages (from-to)734-736
Number of pages3
JournalJournal of Pediatrics
Volume141
Issue number5
DOIs
StatePublished - Nov 1 2002

Fingerprint

Dive into the research topics of 'Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations'. Together they form a unique fingerprint.

Cite this